Published in Antimicrob Agents Chemother on October 01, 1991
Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis (2001) 5.41
Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada. Antimicrob Agents Chemother (1998) 1.91
Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides. Antimicrob Agents Chemother (1994) 1.78
Susceptibilities to 10 antimicrobial agents of 1,220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients. Antimicrob Agents Chemother (1994) 1.69
Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998. Antimicrob Agents Chemother (2000) 1.64
Typing of human Campylobacter jejuni isolates in Finland by pulsed-field gel electrophoresis. J Clin Microbiol (1998) 1.59
Antimicrobial susceptibility patterns of thermophilic Campylobacter spp. from humans, pigs, cattle, and broilers in Denmark. Antimicrob Agents Chemother (1997) 1.58
Campylobacter spp. as a Foodborne Pathogen: A Review. Front Microbiol (2011) 1.41
Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents. Antimicrob Agents Chemother (1993) 1.33
Epidemiology of quinolone resistance: Europe and North and South America. Drugs (1995) 1.22
Susceptibilities of fluoroquinolone-resistant strains of Campylobacter jejuni to 11 oral antimicrobial agents. Antimicrob Agents Chemother (1995) 1.21
Key role of Mfd in the development of fluoroquinolone resistance in Campylobacter jejuni. PLoS Pathog (2008) 1.19
Activities of telithromycin, erythromycin, fluoroquinolones, and doxycycline against Campylobacter strains isolated from Finnish subjects. Antimicrob Agents Chemother (2006) 1.07
Antimicrobial resistance mechanisms among Campylobacter. Biomed Res Int (2013) 1.05
gyrA polymorphism in Campylobacter jejuni: detection of gyrA mutations in 162 C. jejuni isolates by single-strand conformation polymorphism and DNA sequencing. Antimicrob Agents Chemother (2002) 0.94
Bacterial resistance to fluoroquinolones: lessons to be learned. Infection (1994) 0.89
Antimicrobial susceptibilities of Campylobacter strains isolated from Finnish subjects infected domestically or from those infected abroad. Antimicrob Agents Chemother (2003) 0.88
Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline. Antimicrob Agents Chemother (2003) 0.85
The epidemiology of bacterial resistance to quinolones. Drugs (1993) 0.85
Risk factors for antibiotic resistance in Campylobacter spp. isolated from raw poultry meat in Switzerland. BMC Public Health (2003) 0.84
Purulent pleurisy caused by Campylobacter lari. Eur J Clin Microbiol Infect Dis (1998) 0.82
Antibiotic susceptibility of campylobacter isolates from sewage and poultry abattoir drain water. Epidemiol Infect (1995) 0.76
Campylobacter enteritis: a "new" disease. Br Med J (1977) 34.77
Differentiation of enteropathogenic Campylobacter. J Clin Pathol (1980) 9.66
Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens. Eur J Clin Microbiol (1983) 5.62
Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicrob Chemother (1991) 3.71
Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob Agents Chemother (1984) 3.35
Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni. Antimicrob Agents Chemother (1980) 2.71
Campylobacter fetus subspecies jejuni: a common cause of diarrhea in Sweden. J Infect Dis (1980) 2.53
Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Arch Intern Med (1990) 2.45
Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens. Antimicrob Agents Chemother (1985) 2.36
A demographic survey of campylobacter, salmonella and shigella infections in England. A Public Health Laboratory Service Survey. Epidemiol Infect (1987) 2.30
Susceptibility of Campylobacter fetus subsp. jejuni to twenty antimicrobiol agents. Antimicrob Agents Chemother (1979) 2.29
Mechanisms of antibiotic resistance in Campylobacter species. Antimicrob Agents Chemother (1988) 2.26
Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial. Ann Intern Med (1987) 2.05
Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother (1984) 1.67
Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors. Antimicrob Agents Chemother (1985) 1.61
Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea. Am J Med (1987) 1.61
Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species. Antimicrob Agents Chemother (1985) 1.60
Susceptibility of clinical isolates of Campylobacter jejuni to twenty-five antimicrobial agents. J Antimicrob Chemother (1986) 1.57
Characterization of high-level quinolone resistance in Campylobacter jejuni. Antimicrob Agents Chemother (1991) 1.55
Use of norfloxacin in the treatment of acute diarrheal disease. Am J Med (1987) 1.17
Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers' diarrhea. Eur J Clin Microbiol Infect Dis (1989) 1.12
Erythromycin resistance only found in Campylobacter coli. J Antimicrob Chemother (1983) 1.10
Fluoroquinolone-resistance in thermophilic Campylobacter spp isolated from stools of Spanish patients. Lancet (1990) 1.04
Lack of emergence of resistant fecal flora during successful prophylaxis of traveler's diarrhea with norfloxacin. Antimicrob Agents Chemother (1986) 0.98
Norfloxacin versus placebo for prophylaxis against travellers' diarrhoea. J Antimicrob Chemother (1987) 0.92
Revised nomenclature of Campylobacter laridis, Enterobacter intermedium, and "Flavobacterium branchiophila". Int J Syst Bacteriol (1990) 0.91
In vitro susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Austria to erythromycin and ciprofloxacin. Zentralbl Bakteriol (1990) 0.90
In vitro susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Denmark to fourteen antimicrobial agents. Acta Pathol Microbiol Immunol Scand B (1987) 0.89
Ciprofloxacin in the elimination of enteric Salmonella carriage stage. Scand J Infect Dis Suppl (1989) 0.87
In vitro activity of norfloxacin and other antibacterial agents against gastro-intestinal pathogens isolated in Sweden. APMIS (1990) 0.84
Prospective study of the etiology of diarrhea in adult outpatients and inpatients. Scand J Gastroenterol (1989) 0.84
Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group. Lancet (1989) 3.33
Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med (1977) 3.32
Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis (1977) 2.79
Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol (1992) 2.36
Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J Bacteriol (1992) 1.98
Effect of group-A meningococcal vaccine in army recruits in Finland. Lancet (1975) 1.97
Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother (1992) 1.92
Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy. Clin Infect Dis (1992) 1.90
Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol (1992) 1.76
Use of antiserum agar plates for serogrouping of meningococci. J Clin Pathol (1977) 1.74
Low biological activity of Helicobacter pylori lipopolysaccharide. Infect Immun (1992) 1.71
An acid extract as a common antigen in Campylobacter coli and Campylobacter jejuni strains. J Clin Microbiol (1983) 1.65
Serology of Campylobacter fetus ss. jejuni )"related" campylobacters). Demonstration of strain-specific and interstrain-related antigens by immunoelectrophoresis and co-agglutination. Acta Pathol Microbiol Scand B (1980) 1.64
Helicobacter pylori induces lymphocyte activation in peripheral blood cultures. Clin Exp Immunol (1990) 1.62
Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose. J Bacteriol (1991) 1.46
Evidence that cagA(+) Helicobacter pylori strains are disappearing more rapidly than cagA(-) strains. Gut (2002) 1.43
Streptococcus mutans establishment and dental caries experience in children from 2 to 4 years old. Scand J Dent Res (1983) 1.41
Prolonged campylobacter gastroenteritis in a patient with hypogammaglobulinaemia. Acta Med Scand (1983) 1.41
The disc and plate dilution methods in determination of the sensitivity of Neisseria gonorrhoeae to penicillin G, ampicillin and doxycycline. Chemotherapy (1970) 1.41
Campylobacter enteritis in 188 hospitalized patients. Arch Intern Med (1983) 1.41
Serology of Campylobacter fetus ss. jejuni. 2 Serotyping of live bacteria by slide, latex and co-agglutination tests. Acta Pathol Microbiol Immunol Scand B (1982) 1.30
Reactive arthritis after campylobacter jejuni enteritis in patients with HLA-B27. Lancet (1980) 1.29
Arthritis associated with Campylobacter jejuni enteritis. Scand J Rheumatol (1981) 1.27
Beta-haemolytic group A, B, C and G streptococcal septicaemia: a clinical study. Scand J Infect Dis (1988) 1.24
Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro. Arthritis Rheum (1980) 1.21
Vaccination against meningococcal group A disease in Finland 1974-75. Scand J Infect Dis (1976) 1.19
Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol (1996) 1.18
Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease. J Clin Pathol (1996) 1.16
Campylobacter etiology in human gastroenteritis demonstrated by antibodies to acid extract antigen. J Clin Microbiol (1987) 1.16
Effect of erythromycin on the fecal excretion of Campylobacter fetus subspecies jejuni. J Infect Dis (1982) 1.16
Triple therapy of Helicobacter pylori infection in peptic ulcer. A 12-month follow-up study of 93 patients. Scand J Gastroenterol (1992) 1.16
Decreasing prevalence of helicobacter antibodies in Finland, with reference to the decreasing incidence of gastric cancer. Epidemiol Infect (2001) 1.16
Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: comparison of histology, 13C-urea breath test, and serology. Scand J Gastroenterol (2000) 1.13
Effect of ciprofloxacin on carrier rate of Neisseria meningitidis in army recruits in Finland. Antimicrob Agents Chemother (1987) 1.12
Waterborne outbreak of Campylobacter enteritis after outdoors infantry drill in Utti, Finland. Epidemiol Infect (1989) 1.08
Mezlocillin in the treatment of gonorrhoea. Br J Vener Dis (1979) 1.06
Depression of human neutrophil motility by influenza virus in vitro. Scand J Immunol (1977) 1.06
Heterogeneity of Campylobacter pylori as demonstrated by co-agglutination testing with rabbit antibodies. Scand J Gastroenterol Suppl (1988) 1.05
Contact of lymphocytes with Helicobacter pylori augments natural killer cell activity and induces production of gamma interferon. Infect Immun (1993) 1.05
Aminoglycoside resistance among blood culture isolates. J Clin Microbiol (1984) 1.05
Chronic diarrhea due to a single strain of Aeromonas caviae. Eur J Clin Microbiol Infect Dis (1995) 1.04
Spectinomycin hydrochloride in the treatment of uncomplicated gonorrhoea in males and females. Br J Vener Dis (1974) 1.03
High frequency of helicobacter negative gastritis in patients with Crohn's disease. Gut (1996) 1.03
Effect of ABO blood group and secretor status on the frequency of Helicobacter pylori antibodies. Scand J Gastroenterol (1990) 1.03
Clinical and serological studies in patients with Campylobacter fetus ssp. jejuni infection: II. Serological findings. Infection (1981) 1.02
Biochemical characterization of Campylobacter fetus lipopolysaccharides. Infect Immun (1994) 1.02
The emergence and mechanisms of trimethoprim resistance in Escherichia coli isolated from outpatients in Finland. J Antimicrob Chemother (1990) 1.01
Antibodies against an acid extract from a single campylobacter strain in hospitalized campylobacter patients. Infection (1983) 1.01
Carditis and arthritis associated with Campylobacter jejuni infection. Acta Med Scand (1980) 1.01
The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia. Aliment Pharmacol Ther (2002) 1.01
The effect of chemoprophylactic use of rifampin and minocycline on rates of carriage of Neisseria meningitidis in army recruits in Finland. J Infect Dis (1978) 1.00
Defective chemotaxis in monosomy-7. Nature (1977) 0.99
Ribotyping patterns and emergence of metronidazole resistance in paired clinical samples of Helicobacter pylori. J Clin Microbiol (1994) 0.99
Allergy gap between Finnish and Russian Karelia on increase. Allergy (2011) 0.99
Detection of an organ specific protein in the rat thymus. Ann Med Exp Biol Fenn (1966) 0.96
Antimicrobial activity of bupivacaine and morphine. Anesthesiology (1985) 0.96
Pharmacokinetics of single-dose oral ciprofloxacin in infants and small children. Antimicrob Agents Chemother (1992) 0.96
Infection with Campylobacter fetus. Scand J Infect Dis (1984) 0.96
Use of leucocyte migration under agarose to study spontaneous and directed locomotion of leucocytes. Immunology (1978) 0.96
Helicobacter pylori and associated gastroduodenal diseases. Review article. APMIS (1991) 0.96
Pneumococcal bacteraemia during a recent decade. J Infect (1992) 0.95
Analysis of Campylobacter jejuni antigens with monoclonal antibodies. J Clin Microbiol (1984) 0.95
Function of neutrophils in preleukaemia. Scand J Haematol (1977) 0.95
Antimicrobial susceptibility of Arcanobacterium haemolyticum. Antimicrob Agents Chemother (1994) 0.92
Serological analysis of the heat-stable antigens involved in serotyping Campylobacter jejuni and Campylobacter coli. APMIS (1989) 0.92
Fleroxacin versus standard therapy in gonococcal urethritis. J Antimicrob Chemother (1988) 0.92
Increased yields of pathogenic Yersinia enterocolitica strains by cold enrichment. Scand J Infect Dis (1994) 0.91
Genetic and environmental factors in the immunopathogenesis of atopy: interaction of Helicobacter pylori infection and IL4 genetics. Int Arch Allergy Immunol (2005) 0.91
Waterborne Campylobacter jejuni epidemic in a Finnish hospital for rheumatic diseases. Scand J Infect Dis (1990) 0.90
Infection due to Campylobacter jejuni: a report of 524 outpatients. Infection (1984) 0.90
Development of an immunoassay for rapid detection of ganglioside GM(1) mimicry in Campylobacter jejuni strains. J Clin Microbiol (2001) 0.90
Bactericidal effect of bovine normal and immune serum, colostrum and milk against Helicobacter pylori. J Appl Bacteriol (1995) 0.90
Binding of bacterial adhesins to rat glomerular mesangium in vivo. Kidney Int (1993) 0.89
Phagocytic activity of neutrophilic leukocytes of A2 influenza patients. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 0.89
Penetration of erythromycin stearate into maxillary sinus mucosa and secretion in chronic maxillary sinusitis. Acta Otolaryngol (1977) 0.89
Comparative in vitro activity of norfloxacin and seven other antimicrobial agents against clinical isolates from urinary tract infections. Scand J Infect Dis (1985) 0.88
Flavodoxin-dependent pyruvate oxidation, acetate production and metronidazole reduction by Helicobacter pylori. J Antimicrob Chemother (1998) 0.88
Antibiotic concentrations in liquor compared to the minimal inhibitory concentrations of isolates in paediatric bacterial meningitis. The Finnish Study Group. Chemotherapy (1991) 0.88
Hunt for the origin of allergy - comparing the Finnish and Russian Karelia. Clin Exp Allergy (2015) 0.88
The incidence of Pku in Finland. Acta Paediatr Scand (1971) 0.87
In vitro effect of anti-inflammatory agents on phagocytosis and bacterial killing by human neutrophilic leukocytes. Acta Pharmacol Toxicol (Copenh) (1972) 0.87
Leukocyte migration agarose test for the assessment of human neutrophil chemotaxis. II. Variables in the attraction assay. Scand J Immunol (1977) 0.86
Evaluation of the E test in testing susceptibility of Pseudomonas aeruginosa to tobramycin. Eur J Clin Microbiol Infect Dis (1992) 0.86
Treatment of acute bronchitis and pneumonia with cefaclor. Postgrad Med J (1979) 0.86
Change in the pattern of IgE reactivity to timothy grass and birch pollen allergens over a 20-year period. J Investig Allergol Clin Immunol (2006) 0.86
In vitro activity of antifungal azoles against Helicobacter pylori. Eur J Clin Microbiol Infect Dis (1992) 0.86
Epidemiology of invasive Streptococcus pneumoniae infections in adults in Finland. Epidemiol Infect (1997) 0.85
Experimental allergic thyroiditis in the guinea pig. IV. Autoradiographic studies of the evolution of the cellular infiltrate. Lab Invest (1966) 0.85
Sensitivity of gonococcal strains to penicillin G, ampicillin and doxycycline in a Finnish metropolitan material in 1971. Acta Derm Venereol (1973) 0.85
Pancreas affection in association with enteritis due to Campylobacter fetus ssp. jejuni. Acta Med Scand (1981) 0.85
Rate of Helicobacter pylori acquisition among Finnish adults: a fifteen year follow-up. Scand J Gastroenterol (1996) 0.85
Impaired neutrophil chemotaxis in Pelger-Huët anomaly. Clin Exp Immunol (1979) 0.84
Constant defect in neutrophil locomotion but with age decreasing susceptibility to infection in Shwachman syndrome. Clin Exp Immunol (1984) 0.84